Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03556761 · ClinicalTrials.gov registry record · Phase 2
Furosemide for Accelerated Recovery of Blood Pressure Postpartum
A Phase 2 study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- Phase 2
- Development phase
- 384
- Enrollment target
NCT03556761: Completed Phase 2 study, sponsored by University of Pennsylvania.
NCT03556761 is a Phase 2 study that has completed, run by University of Pennsylvania. The registered enrollment target is 384 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03556761, a Phase 2 study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 384 participants
- Enrollment target
Study Summary
A randomized, double-blind, placebo-controlled single center investigation of furosemide's effect on postpartum blood pressure control in pregnancies affected by hypertensive disorders of pregnancy
Interventions
- DRUG Placebo Oral Tablet
- DRUG Oral furosemide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 384 participants |
| Start Date | 2018-06-20 |
| Est. Completion | 2020-02-05 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03556761
The ClinicalTrials.gov registry entry for NCT03556761 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 384 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo Oral Tablet is the first listed.
NCT03556761 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03556761 about?
NCT03556761 is a clinical study titled "Furosemide for Accelerated Recovery of Blood Pressure Postpartum". A randomized, double-blind, placebo-controlled single center investigation of furosemide's effect on postpartum blood pressure control in pregnancies affected by hypertensive disorders of pregnancy
What is the current status of trial NCT03556761?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 384 participants. The study started on 2018-06-20. Estimated completion is 2020-02-05.
What interventions are being tested in trial NCT03556761?
The interventions under investigation include: Placebo Oral Tablet (DRUG), Oral furosemide (DRUG).
Who is sponsoring clinical trial NCT03556761?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.